- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Gracell keeps pace with $100m series C
Lilly Asia Ventures returned for a round that will fund clinical development of Gracell Biotechnologies' immuno-oncology drug pipeline.
Oct 30, 2020Benson Hill beckons corporates to $150m round
The plant-based ingredient developer's series D round was co-led by GV and backed by Louis Dreyfus Company and Emart.
Oct 30, 2020Arable arrows to $20m series B
Grupo Jacto subsidiary Tridon helped the agricultural data technology provider boost its overall funding to $38m./
Oct 30, 2020Kodit homes in on $117m
The Adevinta-backed online property marketplace has secured debt and equity financing in a round led by real estate investor NREP.
Oct 30, 2020Galecto gathers $85m in initial public offering
Novo, Bristol Myers-Squibb and Merck Group scored exits as the fibrosis and cancer drug developer priced its shares in the middle of the IPO's range.
Oct 30, 2020Carlstrom promoted at ABB
ABB's restructuring drive has created a new role for Malin Carlstrom as head of ventures, ABB Electrification
Oct 30, 2020Q32 Bio counts corporates into $60m series B
Sanofi Ventures and Children's Hospital Colorado have returned to back Q32 Bio, an immune regulation-focused university spinout that has now raised at least $106m to date.
Oct 30, 2020Streetbees sees its way to $40m
GMG Ventures came onboard for the market research provider's series B round, which was led by venture firm Lakestar.
Oct 30, 2020University of Dayton propels new accelerator
Propel Dayton is a three-phase accelerator targeting pre-spinout concepts leveraging University of Dayton's intellectual property.
Oct 30, 2020Outrider parks $65m series B
Kraft Heinz's corporate venturing subsidiary joined counterparts at existing investors Koch and Prologis to bring the logistics automation technology producer’s total funding to $118m.
Oct 30, 2020Hepalink helps out ORI fund with $40m
ORI Healthcare Fund II has a target of $400m and pharmaceutical firm Hepalink could potentially provide up to $80m for the vehicle.
Oct 30, 2020Gauss gets series C round to $30m
4100 Group led an extension to the Stanford-StartX Fund-backed healthcare AI technology provider's latest round, which now stands at $30m.
Oct 30, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
